Walleye Capital
REVB icon

Walleye Capital’s Revelation Biosciences REVB Stock Holding History

Walleye Capital’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-72
Closed -$207K – 5905
2023
Q4 		$207K Buy
72
+4
+6% +$14.3K ﹤0.01% 3654
2023
Q3 		$266K Buy
68
+14
+26% +$61.8K ﹤0.01% 3333
2023
Q2 		$293K Buy
54
+24
+80% +$150K 0.01% 2827
2023
Q1 		$227K Buy
+30
New +$810K ﹤0.01% 2367
2021
Q4 		– Hold
0
– -$256 – 2283
2021
Q3 		– Hold
0
– – – 1098
2021
Q2 		– Hold
0
– – – 586
2021
Q1 		– Hold
0
– – – 428

Other funds holding REVB

UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
PIS
POM Investment Strategies Raleigh, North Carolina $80.5M AUM 16.64% 1-Year Est. Return